Skip to main content Accessibility help
×
Home

Prevention of Influenza in Long-Term–Care Facilities

  • Suzanne F. Bradley (a1) and Long-Term–Care Committee of the Society for Healthcare Epidemiology of America

Abstract

Influenza is a frequent cause of epidemic and endemic respiratory illness in long-term-care facilities (LTCFs), resulting in considerable morbidity and mortality. Detection of influenza outbreaks in this setting can be difficult, because the clinical presentation in older adults is atypical and other pathogens also cause influenza-like illness (ILI) during the influenza season. Use of the standard case definition for influenza has not been effective in detecting episodes in residents of LTCFs. Alternative case-definitions that reflect the atypical presentation of influenza in this population have been recommended but not validated. The use of rapid tests for the detection of influenza in conjunction with more sensitive case definitions of ILI may lead to the earlier detection of influenza outbreaks in LTCFs, earlier initiation of infection control measures, and reduction in transmission.

The definition of outbreak, eg, the number of episodes of ILI or episodes of confirmed influenza A that would result in the initiation of antiviral chemoprophylaxis, remains controversial in this setting. The use of newer antivirals could limit the side effects seen in older adults in LTCFs. However, annual vaccination of residents and staff remains the most effective way to prevent the introduction of influenza A or influenza B into LTCFs. In addition, vaccination of LTCF residents reduces rates of illness and pneumonia due to influenza, as well as cardiopulmonary exacerbation, hospitalization, and death.

Copyright

Corresponding author

GRECC 11G, Veterans'Affairs Health Systems, 2215 Fuller Rd, Ann Arbor, MI 48105

Footnotes

Hide All
*

Members of the Long-Term-Care Committee include Lindsay Nicolle, MD (chair), Winnipeg, Manitoba, Canada; Sky Blue, MD, Boise, Ida Suzanne Bradley, MD, Ann Arbor, Michigan; R. Brooks Gainer, MD, Morgantown, West Virginia; Kent Crossley, MD, Minneapolis, Minnesota Freer, MD, Hanover, Pennsylvania; Nelson Gantz, MD, Harrisburg, Pennsylvania; Brenda Nurse, MD, New Britain, Connecticut; Andrew Si MD, Toronto, Ontario, Canada; Philip Smith, MD, Omaha, Nebraska; Larry Strausbaugh, MD, Portland, Oregon; Lauri Thrupp, MD, Ora California.

*

Contributed to the writing of this position

Footnotes

References

Hide All
1. Centers for Disease Control and Prevention. Influenza A—Florida and Tennessee, July-August 1998, and virologie surveillance of influenza, May-August 1998. MMWR 1998;47:2842.
2. Drinka, PJ, Krause, P, Schilling, M, Miller, BA, Shult, P, Gravenstein, S. Report of an outbreak: nursing home architecture and influenza-A attack rates. J Am Geriatr Soc 1996;44:910913.
3. Centers for Disease Control. Outbreak of influenza A in a nursing home— New York, December 1991-January 1992. MMWR 1992;41:129131.
4. Taylor, JL, Dwyer, DM, Coffman, T, Groves, C, Patel, J, Israel, E. Nursing home outbreak of influenza A (H3N2): evaluation of vaccine efficacy and influenza case definitions. Infect Control Hosp Epidemiol 1992;13:9397.
5. Morens, DM, Rash, VM. Lessons from a nursing home outbreak of influenza A Infed Control Hosp Epidemiol 1995;16:275280.
6. Centers for Disease Control. Control of influenza A outbreaks in nursing homes: amantidine as an adjunct to vaccine—Washington, 1989-90. MMWR 1991;40:841844.
7. Degelau, J, Somani, SK, Cooper, SL, Guay, DRP, Crossley, KB. Amantadine-resistant influenza in a nursing facility. Arch Intern Med 1992;152:390392.
8. Peters, NL, Oboler, S, Hair, C, Laxson, L, Kost, J, Meiklejohn, G. Treatment of an influenza A outbreak in a teaching nursing home— effectiveness of a protocol for prevention and control. J Am Geriatr Soc 1989;37:210218.
9. Coles, FB, Balzano, GJ, Morse, DL. An outbreak of influenza A (H3N2) in a well immunized nursing home population. J Am Geriatr Soc 1992;40:589592.
10. Libow, LS, Neufeld, RR, Olson, E, Breuer, B, Starer, P. Sequential outbreak of influenza A and B in a nursing home: efficacy of vaccine and amantidine. J Am Geriatr Soc 1996;44:11531157.
11. Mast, EE, Harmon, MW, Gravenstein, S, Wu, SP, Arden, NH, Circo, R et al. Emergence and possible transmission of amantadine-resistant viruses during nursing home outbreaks of influenza A (H3/N2). Am J Epidemiol 1991;134:988997.
12. Cartter, ML, Renzullo, PO, Helgerson, SD, Martin, SM, Jekel, JF. Influenza outbreaks in nursing homes: how effective is influenza vaccine in the institutionalized elderly? Infect Control Hosp Epidemiol 1990;11:473478.
13. Arden, NH, Patriarca, PA, Fasano, MB, Lui, K-J, Harmon, MW, Kendal, AP, et al. The roles of vaccination and amantidine prophylaxis in controlling an outbreak of influenza A (H3N2) in a nursing home. Arch Intern Med 1988;148:865868.
14. Meiklejohn, G, Hoffman, R, Graves, P. Effectiveness of influenza vaccine when given during an outbreak of influenza A/H3N2 in a nursing home. J Am Geriatr Soc 1989;37:407410.
15. Gross, PA, Quinnan, GV, Rodstein, M, LaMontagne, JR, Kaslow, RA, Saah, AJ, et al. Association of influenza immunization with reduction in mortality in an elderly population. A prospective study. Arch Intern Med 1988;148:562565.
16. Gross, PA, Rodstein, M, LaMontagne, JR, Kaslow, RA, Saah, AJ, Wallenstein, S, et al. Epidemiology of acute respiratory illness during an influenza outbreak in a nursing home: a prospective study. Arch Intern Med 1988;148:559561.
17. Gravenstein, S, Miller, BA, Drinka, P Prevention and control of influenza A outbreaks in long-term care facilities. Infect Control Hosp Epidemiol 1992;13:4954.
18. Arden, N, Monto, AS, Ohmit, SE. Vaccine use and the risk of outbreaks in a sample of nursing homes during an influenza epidemic. Am J Pub Health 1995;85:399401.
19. Gross, PA, Hermogenes, AE, Sacks, HS, Lau, J, Levandowski, RA, The efficacy of influenza vaccine in elderly persons: a meta-analysis and review of the literature. Ann Intern Med 1995;123:518527.
20. Arroyo, JC, Jordan, W Milligan, L. Upper respiratory tract infection and serum antibody responses in nursing home patients. Am J Infect Control 1988;16:152158.
21. Orr, PH, Peeling, RW, Fast, M, Brunka, J, Duckworth, H, Harding, GKM, et al. Serological study of responses to selected pathogens causing respiratory tract infection in the institutionalized elderly. Clin Infect Dis 1996;23:12401245.
22. Potter, J, Statt, DJ, Roberts, MA, Elder, AG, ODonnell, B, Knight, PV, et al. Influenza vaccination of health care workers in long-term-care hospitals reduces the mortality of elderly patients, J Infed Dis 1997;175:16.
23. Monto, AS, Ohmit, SE, Hornbuckle, H, Pearce, CL. Safety and efficacy of long-term use of rimantadine for prophylaxis of type A influenza in nursing homes. Antimicrob Agents Chemother 1995;39:22242228.
24. Treanor, JJ, Mattison, HR, Dumyati, G, Yinnon, A, Erb, S, O'Brien, D, et al. Protective effect of combined live intranasal and inactivated influenza A virus vaccines in the elderly. Ann Intern Med 1992;117:625633.
25. Centers for Disease Control and Prevention. Prevention and control of influenza. Recommendation of the Advisory Committee on Immunization Practice. MMWR 1998;47:126.
26. National Advisory Committee on Immunization. Statement on influenza vaccination for the 1994-95 season. Can Com Dis Report 1994;20:8592.
27. Immunization Against Infectious Diseases. London, UK: Her Majesty's Stationery Office; 1992.
28. Drinka, PJ, Gravenstein, S, Krause, P, Schilling, M, Miller, BA, Shult, E Outbreaks of influenza A and B in a highly immunized nursing home population. J Fam Prac 1997;45:509514.
29. Centers for Disease Control and Prevention. Implementation of the Medicare influenza vaccination benefit—United States, 1993. MMWR 1994;43:771773.
30. Margolis, KL, Nichol, KL, Poland, GA, Pluhar, RE. Frequency of adverse reactions to influenza vaccine in the elderly. A randomized, placebo-controlled trial. JAMA 1990;264:11391141.
31. Ikeda, RM, Drabkin, PD. Influenza outbreaks in nursing homes. J Am Geriatr Soc 1992;12881289.
32. Odelin, MF, Pozzetto, B, Aymard, M, Defayolle, M, Jolly-Million, J. Role of influenza vaccination in the elderly during an epidemic of A/H1N1 virus in 1988-1989: clinical and serological data. Gerontology 1993;39:109116.
33. Tannenbaum, TN, Thomas, D, Baumgarten, M, Saintonge, F, Rohan, I. Evaluation of an influenza vaccination program for nursing home staff. Can J Pub Health 1993;84:6062.
34. Nichol, KL, Grimm, MB, Peterson, DC. Immunization in long term care facilities. Policies and practice. J Am Geriatr Soc 1996;44:349355.
35. Horman, JT, Stetler, HC, Israel, E, Sorley, D, Schipper, MT, Joseph, JM. An outbreak of influenza in a nursing home. Am J Pub Health 1986;76:501504.
36. Arroyo, JC, Postie, B, Brown, A, Harrison, K, Birgenheier, R, Dowda, H. Influenza A/Philipines/2/82 outbreak in a nursing home: limitations of influenza vaccination in the aged. Am J Infed Control 1984;12:329334.
37. Beyer, WER, Palache, AM, Sprenger, MJW, Hendriksen, E, Tukker, JJ, Darioli, R, et al. Effects of repeated annual influenza vaccination on vaccine sero-response in young and elderly adults. Vaccine 1996;14:13311339.
38. Nichol, KL, Margolis, KL, Wouremna, J, Von Sternberg, T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 1994;331:778784.
39. Fedson, DS, Wajda, A, Nichol, JP, Roos, LL. Disparity between influenza vaccination rates and risks for influenza-associated hospital discharge and death in Manitoba in 1982-1983. Ann Intern Med 1992;116:550555.
40. Govaert, ThME, Thijs, CTMCN, Masurel, N, Sprenger, MJW, Dinant, GJ, Knotterus, JA, The efficacy of influenza vaccination in elderly individuals: a randomized double-blind placebo-controlled trial. JAMA 1994;272:16611665.
41. Foster, DA, Talsma, A, Furumoto-Dawson, A, Ohmit, SE, Margulies, JR, Arden, NH, et al. Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly. Am J Epidemiol 1992;136:296307.
42. Mullooly, JR, Bennett, MD, Hornbrook, MC, Barker, WH, Williams, WW, Patriarca, PA, et al. Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization. Ann Intern Med 1994;121:947952.
43. Fleming, DM, Watson, JM, Nicholas, S, Smith, GE, Swan, AV. Study of the effectiveness of influenza vaccination in the elderly in the epidemic of 1989-90 using a general practice database. Epidemiol Infect 1995;115:581589.
44. Carrat, F, Valieron, A-J. Influenza mortality among the elderly in France, 1980-1990: how many deaths may have been avoided through vaccination? J Epidemiol Commun Health 1995;49:419425.
45. Puig-Barbera, J, Marquez-Calderon, S, Masoliver-Fores, A, Lloria-Paes, F, Ortega-Dicha, A, Gil-Martin, M, et al. Reduction in hospital admissions for pneumonia in non-institutionalized elderly people as a result of influenza vaccination: a case-control study in Spain. J Epidemiol Commun Health 1997;51:526530.
46. Ruben, FL, Johnston, F, Streiff, EJ. Influenza in a partially immunized aged population: effectiveness of killed Hong Kong vaccine against infection with the England strain. JAMA 1974;230:863866.
47. Patriarca, PA, Weber, JA, Parker, RA, Hall, WN, Kendal, AP, Bergman, DJ, et al. Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic. JAMA 1985;253:11361139.
48. Goodman, RA, Orenstein, WA, Munro, TF, Smith, SC, Sikes, RK, Impact of influenza A in a nursing home. JAMA 1982;247:14511453.
49. Patriarca, PA, Weber, JA, Parker, RA, Orenstein, WA, Hall, WN, Kendal, AP, et al. Risk factors for outbreaks of influenza in nursing homes. A case-control study. Am J Epidemiol 1986;124:114119.
50. Remarque, EJ, Cools, HJM, Boere, TJ, van der His, RJ, Masurel, N, Iighthart, GJ. Functional disability and antibody response to influenza vaccine in elderly patients in a Dutch nursing home. BMJ 1996;312:1015.
51. Powers, DC. Effect of age on serum immunoglobulin G subclass antibody responses to inactivated influenza virus vaccine. J Med Virol 1994;43:5761.
52. McElhaney, JE, Beattie, BL, Devine, R, Grynoch R Toth, EL, Bleackley, RC. Age-related decline in interleukin-2 production in response to influenza vaccine. J Am Geriatr Soc 1990;38:652658.
53. Powers, DC. Influenza A virus-specific cytotoxic T lymphocyte activity declines with advancing age. J Am Geriatr Soc 1993;41:15.
54. Powers, DC, Belshe, RB. Effect of age on cytotoxic T lymphocyte memory as well as serum and local antibody responses elicited by inactivated influenza virus vaccine. J Infect Dis 1993;167:584592.
55. McElhaney, JE, Meneilly, GS, Lechelt, KE, Bleackley, RC. Split-virus influenza vaccines: do they provide adequate immunity in the elderly. J Gerontol 1994;49:M37M43.
56. Zei, T, Neri, M, Iorio, AM. Immunogenicity of trivalent subunit and split influenza vaccines (1989-90 winter season) in volunteers of different groups of age. Vaccine 1991;9:613617.
57. Palache, AM, Beyer, WEP, Sprenger MJW, Masurel, N, de Jonge, S, Vardy, A, et al. Antibody response after influenza immunization with various vaccine doses: a double-blind, placebo-controlled, multi-centre, dose-response study in elderly nursing-home residents and young volunteers. Vaccine 1993;11:39.
58. Wali, A, Cherniack, EP, Ehrleiter, D, Doria, G, Gross, R, Russo, C, et al. Revaccination augments anti-influenza antibody response in elderly humans. Aging: Immunology and Infectious Disease 1992;3:185194.
59. Brands, R Palache, AM, van Scharrenburg, GJM. Madin Darby Canine Kidney (MDCK)—cells for the production of inactivated influenza sub-unit vaccine. Safety characteristics and clinical results in the elderly. In: Brown, LE, Hampson, AW, Webster, RG, eds. Options for the Control of Influenza. Amsterdam, The Netherlands: Elsevier Science BV 1996:683693.
60. Treanor, JJ, Betts, RF, Smith, GE, Anderson, EL, Hackett, CS, Wilkinson, BE, et al. Evaluation of a recombinant hemagglutinin expressed in insect cells as an influenza vaccine in young and elderly adults. J Infed Dis 1996;173:14671470.
61. Gravenstein, S, Drinka, P, Duthie, EH, Miller, BA, Brown, CS, Hensley, M, et al. Efficacy of an influenza hemagglutinin-diphtheria toxoid conjugate vaccine in elderly nursing home subjects during an influenza outbreak. J Am Geriatr Soc 1994;42:245251.
62. Gluck, R, Mischler, R, Finkel, B, Que, JU, Carpa, B, Cryz, SJ. Immunogenicity of new virosome influenza vaccine in elderly people. Lancet 1994;344:160163.
63. Degelau, JJ, Guay, D, Hallgren, H. The effect of DHEAS on influenza vaccination in aging adults. J Am Geriatr Soc 1997;45:747751.
64. Provinciali, M, Di Stefano, G, Colombo, M, Della Croce, F, Gandolfi, MC, Daghetta, L, et al. Adjuvant effect of low-dose interleukin-2 on antibody response to influenza virus vaccination in healthy elderly subjects. Mech Age Develop 1994;77:7582.
65. Powers, DC. Summary of a clinical trial with liposome-adjuvanted influenza A virus vaccine in the elderly. Mech Age Develop 1997;93:179188.
66. Gorse, GJ, Belshe, RB, Munn, NJ. Safety of and serum antibody response to cold-recombinant influenza A and inactivated trivalent influenza virus vaccines in older adults with chronic diseases. J Clin Microbiol 1986;24:336342.
67. Treanor, J, Dumyati, G, O'Brien, D, Riley, MA, Riley, G, Erb, S, et al. Evaluation of cold-adapted, reassortant influenza B virus vaccines in elderly and chronically ill adults. J Infect Dis 1994;169:402407.
68. Budnick, LD, Stricof, RL, Ellis, E An outbreak of influenza A in a nursing home. NY State J Med 1984;84:235238.
69. Houck, P, Hemphill, M, LaCroix, S, Hirsh, D, Cox, N. Amantadine-resistant influenza A in nursing homes—identification of a resistant virus prior to drug use. Arch Intern Med 1995;155:533537.
70. Stange, KC, little, DW, Blatnik, B. Adverse reactions to amantadine prophylaxis of influenza in a retirement home. J Am Geriatr Soc 1991;39:700705.
71. Delagau, J, Somani, S, Cooper, SL, Irvine, PW. Occurrence of adverse effects and high amantadine concentrations with influenza prophylaxis in a nursing home. J Am Geriatr Soc 1990;38:428432.
72. Patriarca, PA, Arden, NH, Koplan, JP, Goodman, RA, Prevention and control of type A influenza infections in nursing homes. Ann Intern Med 1987;107:732740.
73. Tamblyn, SE. Amantidine use in influenza outbreaks in long-term care facilities. Can Med Assoc J 1997;157:15731574.
74. Patriarca, PA, Kater, NA, Kendal, AP, Bregman, DJ, Smith, JD, Sikes, K Safety of prolonged administration of rimantadine hydrochloride in the prophylaxis of influenza A virus infections in nursing homes. Antimicrob Agents Chemother 1984;26:101103.
75. Schilling, M, Povinelli, L, Krause, P, Gravenstein, M, Ambrozaitis A Jones, HH, et al. Efficacy of zanamivir for chemoprophylaxis of nursing home influenza outbreaks. Vaccine 1998;16:17711774.
76. Gubareva, LV, Matrosovich, MN, Brenner, MK, Bethell, RC, Webster, RG. Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus. J Infect Dis 1998;178:12571262.
77. Betts, RE, Influenza virus. In: Mandeli, GL, Bennet, JE, Dolin, R eds. Principles and Practice of Infectious Diseases. 4th ed. New York, NY: Churchill Livingstone; 1995;15461567.
78. Cate, TR, Clinical manifestations and consequences of influenza. Am J Med 1987;82(6a):1519.
79. Wald, TG, Miller, BA, Shult, R Drinka, R Langer, L, Gravenstein, S. Can respiratory synctial virus and influenza A be distinguished clinically in institutionalized older persons? J Am Geriatr Soc 1995;43:170174.
80. Falsey, A, Treanor, JJ, Betts, RF, Walsh, EE. Viral respiratory infections in the institutionalized elderly: clinical and epidemiological findings. J Am Geriatr Soc 1992;40:115119.
81. Janssens, J-P, Gauthey, L, Herrmann, F, katch, T, Michel, JE, Community-acquired pneumonia in older patients. J Am Geriatrics Soc 1996;44:539544.
82. Falsey, A Noninfluenza respiratory virus infection in long-term care facilities. Infect Control Hosp Epidemiol 1991;12:602608.
83. Troy, CJ, Peeling, RW, Ellis, AG, Hockin, JC, Bennett, DA, Murphy, MR, et al. Chlamydia pneumoniae as a new source of infectious outbreaks in nursing homes. JAMA 1997;277:12141218.
84. Mathur, U, Bentley, DW, Hall, CB. Concurrent respiratory syncytial virus and influenza A infections in the institutionalized elderly and chronically ill. Ann Intern Med 1980;93(S1):4952.
85. Falsey, AR, Walsh, EE, Betts, RF. Serologic evidence of respiratory syncytial virus infection in nursing home patients. J Infect Dis 1990;162:568569.
86. McGeer, A, Campbell, B, Emori, TG, Hierholzer, WJ, Jackson, MM, Nicolle, LE, et al. Definitions of infections for surveillance in long-term care facilities. Am J Infect Control 1991;19:17.
87. Gomolin, IH, Leib, HB, Arden, NH, Sherman, FT. Control of influenza outbreaks in the nursing home: guidelines for diagnosis and management. J Am Geriatr Soc 1995;43:7174.
88. Gravenstein, S, Miller, BA, Ershler, WB, Brown, CS, Mast, E, Circo, R, et al. Low sensitivity of CDC case definition for H3N2 influenza in elderly nursing home subjects. Clinical Research 1990;38:547A
89. Simor, AE, Augustin A, Staynor, K, Clark, BA, Petrie, M, Kasupski, G, et al. Influenza A in elderly nursing home residents: evaluation of vaccine efficacy and case definitions of influenza-like illness. Presented at the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy meeting; October 17-20, 1993; New Orleans, LA. Abstract 1383.
90. Waner, JL, Todd, SJ, Shalaby, H, Murphy, P, Wall, LV. Comparison of Directigen FLU-A with viral isolation and direct immunofluorescence for the rapid detection and identification of influenza A virus. J Clin Microbiol 1991;29:479482.
91. Johnston, SLG, Bloy, H. Evaluation of a rapid enzyme immunoassay for detection of influenza A virus. J Clin Microbiol 1993;31:142143.
92. Leonardi, GR, Leib, H, Birkhead, GS, Smith, C, Costello, P, Conron, W. Comparison of rapid detection methods for influenza A virus and their value in health-care management of institutionalized geriatric patients. J Clin Microbiol 1994;32:7074.
93. Morens, DM, Rash, VM. Lessons from a nursing home outbreak of influenza A. Infect Control Hosp Epidemiol 1995;16:275280.
94. Gravenstein, S, Miller, BA, Drinka, P. Prevention and control of influenza A outbreaks in long-term care facilities. Infect Control Hosp Epidemiol 1992;13:4954.
95. Hall, WN, Goodman, RA, Noble, GR, Kendal, AP, Steece, RS. An outbreak of influenza B in an elderly population. J Infect Dis 1981;144:297302.
96. Drinka, PJ, Gravenstein, S, Schilling, M, Krause, P, Miller, BA, Duration of antiviral prophylaxis during nursing home outbreaks of influenza A A comparison of 2 protocols. Arch Intern Med 1998;158:21552159.
97. Garner, JS, Hospital Inspection Control Practices Advisory Committee. Guideline for isolation precautions in hospitals. Infed Control Hosp Epidemiol 1996;17:5380.
98. Tablan, O, Anderson, IJ, Arden, NH, Breiman, RF, Butler, JC, McNeil, MM, et al. Guidelines for prevention of nosocomial pneumonia. Infect Control Hosp Epidemiol 1994;15:587627.
99. Gravenstein, S. Strategies to limit influenza in a nursing home. Geriatric Focus 1992;2:111.
100. AIDS/TB, Committee of the Society for Healthcare Epidemiology of America. Management of healthcare workers infected with hepatitis B virus, hepatitis C virus, human immunodeficiency virus, or other blood-borne pathogens. Infed Control Hosp Epidemiol 1997;18:349363.

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed